331 related articles for article (PubMed ID: 18223224)
1. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
4. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
Noordhuis MG; Eijsink JJ; Ten Hoor KA; Roossink F; Hollema H; Arts HJ; Pras E; Maduro JH; Reyners AK; de Bock GH; Wisman GB; Schuuring E; van der Zee AG
Clin Cancer Res; 2009 Dec; 15(23):7389-97. PubMed ID: 19920104
[TBL] [Abstract][Full Text] [Related]
6. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
Als AB; Dyrskjøt L; von der Maase H; Koed K; Mansilla F; Toldbod HE; Jensen JL; Ulhøi BP; Sengeløv L; Jensen KM; Orntoft TF
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4407-14. PubMed ID: 17671123
[TBL] [Abstract][Full Text] [Related]
7. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
[TBL] [Abstract][Full Text] [Related]
9. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloprotease inducer stimulates fibroblast-mediated tumor growth in vivo.
Rosenthal EL; Vidrine DM; Zhang W
Laryngoscope; 2006 Jul; 116(7):1086-92. PubMed ID: 16826041
[TBL] [Abstract][Full Text] [Related]
11. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
[TBL] [Abstract][Full Text] [Related]
12. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
[TBL] [Abstract][Full Text] [Related]
13. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
15. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy.
Chen HH; Su WC; Chou CY; Guo HR; Ho SY; Que J; Lee WY
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1093-100. PubMed ID: 16099602
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
18. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
[TBL] [Abstract][Full Text] [Related]
19. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
[TBL] [Abstract][Full Text] [Related]
20. High expression of HER3 is associated with a decreased survival in gastric cancer.
Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]